A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer
This study has been withdrawn prior to enrollment.
First Posted: September 6, 2004
Last Update Posted: May 10, 2012
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|